Cai et al. investigated the glucagon-like peptide 1 (GLP-1), an insulin tropic peptide, which showed potential for diabetes treatment [1163,1164] due to its anti-oxidative properties [1165,1166]. This evidence concerns the gene GCG and diabetes mellitus.